IR is defined as an impaired biologic response to insulin stimulation of target tissues resulting in a compensatory increase in insulin production and hyperinsulinemia (Shanik et al., 2008; Freeman and Pennings, 2022). The gene discussed is INS; the disease is hyperinsulinism.